Viking Therapeutics Has $502 Million in Cash and 1 Big Catalyst Left in 2026 -- Is That Enough?
Key PointsViking's strong cash position funds operations through major milestones in 2027 and 2028.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.